Font Size: a A A
Keyword [pathological complete response]
Result: 21 - 40 | Page: 2 of 3
21. The Relationship Between The Expression Of TOP2A Protein And Its Different Expression Levels In Breast Cancer Tissues And The Efficacy Of Anthracycline Combined With Taxane Neoadjuvant Chemotherapy
22. Analysis Of Axillary Lymph Node Status In Patients With Breast Pathological Complete Response After Neoadjuvant Chemotherapy
23. Effect Of Interval Time Between Neoadjuvant Chemoradiotherapy And Operation For Rectal Cancer On Clinical And Oncological Outcome
24. Clinical Predictors Of Short Term Efficacy After Neoadjuvant Chemoradiotherapy In Locally Advanced Rectal Cancer
25. Establishment Of A Comprehensive Prediction Model For Pathologic Complete Response After Neoadjuvant Chemotherapy
26. Analysis Of Risk Factors For Recurrence And Matastasis In Breast Cancer Patients With A Pathologic Complete Response After Neoadjuvant Chemotherapy
27. Analysis Of Prognostic Factors In Breast Cancer Patients With Non-pathological Complete Response After Neo-adjuvant Chemotherapy
28. Development and Validation of a Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy for Breast Cancer
29. Expression And Prognostic Significance Of Indoleamine-2,3-Dioxygenase-1 In Advanced Colorectal Cancer
30. 1.Combining Blood Indicators Before Neoadjuvant Chemoradiotherapy To Predict Treatment Response And Prognosis Of Patients With Locally Advanced Rectal Cancer 2.Clinicopathological Characteristics And Prognostic Analysis Of Patients With Pathological Comp
31. Application Of Propensity Score Matching To Explore The Effect Of Type 2 Diabetes Mellitus On The Efficacy Of Neoadjuvant Chemotherapy For Breast Cancer
32. Radiomic Features Based On MRI And Pathology As Predictors Of Pathological Complete Response To Neoadjuvant Chemoradiotherapy In Locally Advanced Rectal Caner
33. The Value Of Three-dimensional Endorectal Ultrasound In Diagnosing TN Staging For Advanced Rectal Cancer After Preoperative Chemoradiation Therapy
34. Changes Of Blood Lipids And Predictive Analysis Of PCR After Neoadjuvant Radiotherapy And Chemotherapy In Stage ? Rectal Cancer
35. Analysis Of Prognostic Factors In Patients With Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
36. Efficacy And Influencing Factors Of Pertuzumab Combined With Trastuzumab In The Neoadjuvant Therapy Of HERT-2 Positive Breast Cancer
37. Correlative Factors And Prediction Model Construction Of Pathological Complete Response To Neoadjuvant Chemotherapy In Breast Cancer
38. Segmentation Of Breast Cancer And Prediction Of Immune Complete Response To Neoadjuvnat Chemotherapy
39. Predictive Value Of HER2 Protein Expression Level In Pat Ients With HER2-positive Breast Cancer Receiving Neoadj Uvant Therapy
40. Application Value Of Serum VEGF In Neoadjuvant Chemotherapy Of Triple-Negative Breast Cancer
  <<First  <Prev  Next>  Last>>  Jump to